Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$77.8M |
| 2 |
Zoom
ZM
|
+$65.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$56.4M |
| 4 |
Peloton Interactive
PTON
|
+$56.1M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$189M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
PPLI
People Inc
PPLI
|
+$80.9M |
| 4 |
Amazon
AMZN
|
+$73.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$54.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.37% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
1951
Alexander's
ALX
$1.4B
| $1.27M | ﹤0.01% |
5,200
+100
| +2% | +$25.3K |
|
1952
ATN International
ATNI
$491M
| $1.27M | ﹤0.01% |
25,400
+500
| +2% | +$28.6K |
|
|
CKH
1953
DELISTED
Seacor Holdings Inc.
CKH
| $1.27M | ﹤0.01% |
43,800
+1,000
| +2% | +$29.7K |
|
|
TBIO
1954
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.27M | ﹤0.01% |
93,300
+1,400
| +2% | +$21.6K |
|
|
TBI
1955
Trueblue
TBI
$309M
| $1.27M | ﹤0.01% |
81,900
-4,300
| -5% | -$66.3K |
|
1956
Omeros
OMER
$1.26B
| $1.27M | ﹤0.01% |
125,300
+17,400
| +16% | +$224K |
|
1957
LeMaitre Vascular
LMAT
$1.87B
| $1.26M | ﹤0.01% |
38,900
+1,000
| +3% | +$30K |
|
1958
Health Catalyst
HCAT
$132M
| $1.26M | ﹤0.01% |
34,500
+1,200
| +4% | +$40.8K |
|
1959
E.W. Scripps
SSP
$310M
| $1.26M | ﹤0.01% |
110,216
+2,400
| +2% | +$26.2K |
|
1960
Revolution Medicines
RVMD
$43.3B
| $1.26M | ﹤0.01% |
36,200
+9,900
| +38% | +$274K |
|
1961
Acco Brands
ACCO
$399M
| $1.26M | ﹤0.01% |
216,500
| – | – |
|
1962
World Acceptance Corp
WRLD
$875M
| $1.26M | ﹤0.01% |
11,900
-500
| -4% | -$41.6K |
|
1963
GoPro
GPRO
$117M
| $1.25M | ﹤0.01% |
277,100
+7,600
| +3% | +$35.7K |
|
1964
Tootsie Roll Industries
TR
$3.02B
| $1.25M | ﹤0.01% |
48,442
+1,672
| +4% | +$44.6K |
|
1965
PDF Solutions
PDFS
$2.13B
| $1.25M | ﹤0.01% |
66,900
+2,000
| +3% | +$41.2K |
|
1966
MarineMax
HZO
$1.15B
| $1.25M | ﹤0.01% |
48,700
+700
| +1% | +$19.2K |
|
1967
York Water
YORW
$536M
| $1.25M | ﹤0.01% |
29,500
+500
| +2% | +$22.9K |
|
1968
Krystal Biotech
KRYS
$9.72B
| $1.24M | ﹤0.01% |
28,900
+500
| +2% | +$21.7K |
|
|
LGF.A
1969
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.24M | ﹤0.01% |
130,950
| – | – |
|
|
INN
1970
Summit Hotel Properties
INN
$656M
| $1.24M | ﹤0.01% |
239,300
+4,600
| +2% | +$26K |
|
|
ANAT
1971
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.24M | ﹤0.01% |
18,313
+300
| +2% | +$21.8K |
|
|
NVEE
1972
DELISTED
NV5 Global
NVEE
| $1.24M | ﹤0.01% |
93,600
| – | – |
|
1973
HealthStream
HSTM
$849M
| $1.23M | ﹤0.01% |
61,500
| – | – |
|
1974
Kenon Holdings
KEN
$3.53B
| $1.23M | ﹤0.01% |
54,625
| – | – |
|
1975
Inogen
INGN
$154M
| $1.23M | ﹤0.01% |
42,500
+700
| +2% | +$22K |
|
Similar funds
Swiss National Bank's Q3 2020 Portfolio in Review
As of Q3 2020, Swiss National Bank held 2,445 positions worth $128B, up 8.1% from $118B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 0.9%. Swiss National Bank opened 7 new positions and exited 15, leaving the 2,445-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2020 buy was Peloton Interactive: 762,000 shares worth $75.6M.
- Swiss National Bank added most to Match Group in Q3 2020, an estimated $77.8M increase.
- Swiss National Bank's biggest Q3 2020 reduction was Apple, cutting an estimated $189M.
- Swiss National Bank fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $14.8M.
- Swiss National Bank's ten largest holdings make up 24% of its $128B portfolio in Q3 2020.
- Swiss National Bank opened 7 new positions and closed 15 in Q3 2020.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $128B.
Based on Swiss National Bank's 13F filing for Q3 2020, filed 9 Nov 2020.